Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 11 July 2023
Sec. General Cardiovascular Medicine
Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1250733

Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy

This article is a correction to:

  1. The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy

    1. Read original article
\r\nZehao Zhao,,Zehao Zhao1,2,3Shutong Dong,,Shutong Dong1,2,3Tienan Sun,,Tienan Sun1,2,3Kangning Han,,Kangning Han1,2,3Xin Huang,,Xin Huang1,2,3Meishi Ma,,Meishi Ma1,2,3Shiwei Yang,, Shiwei Yang1,2,3*Yujie Zhou,, \r\nYujie Zhou1,2,3*
  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
  • 2Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China
  • 3Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China

A Corrigendum on

The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy

By Zhao Z, Dong S, Sun T, Han K, Huang X, Ma M, Yang S and Zhou Y. (2023) Front. Cardiovasc. Med. 10:1115142. doi: 10.3389/fcvm.2023.1115142

Incorrect Funding

In the published article, there was an error in the Funding statement. The correct Funding statement appears below.

FUNDING

This work was supported by grants from the National Key Research and Development Program of China (2017YFC0908800), Pilot Projects for Public Welfare Development of Beijing Municipal Medical Institute “Precise medicine and interventional diagnosis and treatment platform for coronary heart disease” (2019-3), Capital's Funds for Health Improvement and Research (CFH 2020-2-2063) and Beijing Municipal Natural Science Foundation (7202041).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: free fatty acids (FFA), coronary artery disease, clopidogrel, platelet reactivity, thromboelastogram, percutaneous coronary intervention

Citation: Zhao Z, Dong S, Sun T, Han K, Huang X, Ma M, Yang S and Zhou Y (2023) Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy. Front. Cardiovasc. Med. 10:1250733. doi: 10.3389/fcvm.2023.1250733

Received: 30 June 2023; Accepted: 3 July 2023;
Published: 11 July 2023.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

© 2023 Zhao, Dong, Sun, Han, Huang, Ma, Yang and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Shiwei Yang amFja3lkYW5nQDE2My5jb20= Yujie Zhou YXp6eWoxMkAxNjMuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.